Head and Neck Cancers

A Phase I Trial of 96-Hour Paclitaxel Infusion Plus Accelerated Radiotherapy for Unresectable Head and Neck Cancer An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer Chemoradiotherapy versus Radiotherapy in Patients with Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup Study 0099 Chemoradiotherapy Versus Radiotherapy in Patients With Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup Study 0099 Evidence for a Causal Association Between Human Papillomavirus and a subset of Head and Neck Cancers Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer Phase III Study of Concurrent Chemoradiotherapy versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck, RTOG 9501/Intergroup Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group Preradiotherapy Computed Tomography as a Predictor for Local Control in Supraglottic Carcinoma Recurrences after Conformal Parotid-Sparing Radiotherapy Simultaneous Radiochemotherapy versus Radiotherapy Alone in Advanced Head and Neck Cancer: a Randomized Multi-center Study The Impact of Nutritional Status on the Prognoses of Patients with Advanced Head and Neck Cancer